Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine

Usage statistics
Plots

Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine - Inamdar, Kedar V. et al - ART-2009-129738

Main file(s):

Universidad de Zaragoza Repository :: :: :: ::

© Biblioteca Universidad de Zaragoza
© Servicio de Informática y Comunicaciones de la Universidad de Zaragoza
Aviso legal | Condiciones de uso | Política de privacidad

Política del Repositorio

This site is also available in the following languages:
English Español Français

unizar.es

Aviso Legal
Condiciones generales de uso
Politica de Privacidad